Das Geschäft mit dem Blut - ARTE DOKU 2017

Chnopfloch
5 Abonnenten
23 Videoaufrufe·16.10.2023
Blut ist nicht nur eine lebenswichtige Körperflüssigkeit, sondern auch begehrter Rohstoff für Medikamente. THEMA blickt hinter die Kulissen der Pharmaindustrie und berichtet über die Rohstofflieferanten, die Plasma spenden – nicht nur um anderen zu helfen, sondern um selbst zu überleben. Die Dokumentation folgt dem Weg einer Blutkonserve aus einem Armenviertel in den USA nach Deutschland, Frankreich und in die Schweiz und zeigt auch Blutspender, die protestieren.
Quelle: Ntv
Welcome to the wonderful world of blood donation.
Everywhere in the world, blood donation is a sign of generosity.
Donating blood is considered a very honorable thing in our society.
But behind good intentions, there is a completely different reality.
The healthcare industry is the perfect money machine,
because we are ready to pay for all available therapies.
In the center of this business is blood plasma.
This yellow, protein-rich liquid, which makes up the largest part of the blood, is more expensive than raw oil.
This is exploitation of people by people.
Some call it a new form of cannibalism.
Do we accept this?
This system in which a rich man benefits from a poor man?
I am like a cow that gives milk.
Absurd.
That almost killed me. I don't want to do this anymore.
It's disgusting.
We look behind the scenes of a widely unknown area of the healthcare industry.
The business with blood.
Our research leads us to France, Germany and the United States.
They don't allow us to interview the blood donors.
And do you know why?
Because it's not right what they do.
The public wants to know something about it.
Carlos comes to donate blood today.
He regularly donates blood at the Swiss Red Cross near Lausanne.
He sees in it a sign of his commitment to the public.
More than 100 million blood donations are collected worldwide every year.
In 2015, the Red Cross registered 311,000 blood donations in Switzerland.
But the numbers are declining.
The organization is constantly looking for new donors.
Their message is clear.
Donating blood means saving lives.
It's important to me.
Because I know that I can help sick people with it.
That's crucial for me.
That's my way of helping people.
I think it's nice to be able to give something of yourself.
Blood is a special kind of juice, says Mephisto in Goethe's Faust.
And not only for him it's a special kind of juice.
Blood donations are part of the health industry.
And they are subject to the laws of the market.
That's going well.
Thank you.
I'll get you some grape juice now.
That's nice.
In Switzerland, blood donors have to fill out a medical questionnaire
with which they are informed at the same time and confirm their consent.
The devil is, as always, in the details.
In the small print it says,
I am aware that certain parts of my donation can be used for the production of medicines.
This line at the end of the form is only read by a few donors.
It contains important information.
The largest part of the blood is actually given to private companies,
as the Red Cross confirms to us.
We receive about 320,000 blood donations per year.
These are full blood donations,
which means that all parts of the blood are made of plasma.
And what do you do with blood plasma?
In contrast to other parts of the blood,
only about 20% of the plasma is used in hospitals.
Used in hospitals means for patients who have a high blood loss
and have to maintain this volume.
The remaining part, which is almost 80%,
goes into the so-called fractioning industry.
These are companies that produce stable blood products and medicines from it.
The fractioning industry.
These are pharmaceutical companies that buy 80,000 liters of plasma from the Red Cross every year.
The humanitarian institution that has the monopoly on blood donations in Switzerland
receives 10 million Swiss francs per year.
What do you know about the blood that you have just donated?
I have to admit that I don't know much about it.
I didn't get much information about it.
When I hear the word blood donation,
it means that I donate my blood.
But what comes out of this blood?
I hope that it will be used in hospitals nearby.
That's at least the idea I have of blood donations.
Maybe it's pretty naive.
First insight.
The largest part of the donated blood is sold to pharmaceutical companies.
And if the industry is so interested in the blood of Carlos,
then there are reasons for that.
The liquid part, the blood plasma, contains very desirable proteins.
They are used for the production of expensive and very penetrating drugs.
Who are the companies that turn donated blood into liquid gold?
We decide to follow the path of plasma.
Welcome to CSL Plasma.
Typically, 57% of our blood volume is made up of plasma.
Plasma is a strong colored liquid portion of the whole blood
that transports water and nutrients to all cells in the body.
It is composed of approximately 90% water and 10% protein.
The plasma industry is gigantic.
A handful of companies share the world market.
The American company Baxter,
the Australian CSL Behring,
the Spanish Grifols,
and the Swiss company Octa Pharma.
Octa Pharma's raw material is produced by the perfect bioreactor
developed over millions of years of evolution, the human body.
For these companies, plasma is a very lucrative raw material.
When fractioning, drugs are made from the plasma of the donors.
Thousands of liters of human blood plasma are collected,
frozen and mixed.
These companies control a growing market
with a volume of 17 billion dollars.
The president and founder of the Swiss Octa Pharma, Wolfgang Mager,
is a very reserved personality.
His fortune is estimated by Forbes magazine at 6 billion dollars.
Here is one of his rare statements in public.
And they will be required, for some patient groups,
as a lifelong therapy.
Presumably they're covered by most insurance companies.
Yes, they have to be, as they're very expensive.
But that is also the other part of the same coin.
There are many countries who simply cannot afford
to provide this kind of level of treatment
to their population yet, at least.
And it sounds easy when you say,
well, plasma should be available enough.
You just go to your population, your country,
you collect the plasma, and then you'll be in good shape
when you make those products.
That's not the case.
Now a truly global organization,
Octa Pharma remains a family business dedicated
to always going further to empower more patients
to go further in their life adventure.
All over the world, the lives of millions of patients
depend on such drugs.
One of them is Tamara.
Today she's coming to her therapy session
at the Bern hospital.
Since her childhood, she's been suffering from an immune weakness
that leads to infections again and again.
Hey, Tamara.
Good morning.
Are you okay?
Yes.
Through the treatment on the basis of blood plasma,
Tamara's life has become easier.
She can no longer imagine herself
without it.
Before I got the infusion,
I couldn't say for about two years
that I was healthy
or that I was doing well.
And that has already changed.
Now it's purely related to the infections.
I come here every three weeks
to get the infusion.
Yes.
And then it goes on.
Every time it goes on for about three to four hours.
So they're actually immune globulins.
In other words,
it's an important part of immune defense.
And the antibodies that you can't produce yourself
are simply added from the outside.
I work in a pharmacy,
so I know the prices.
The big bottle is around 1,500 francs,
and the smaller one is around 1,000 francs.
So in total, today...
It's about 4,000 francs.
I'm happy to donate blood,
not just because of our medication,
but in general.
And I always draw people's attention to it.
So we're kind of
in the circle of relatives.
Or, yes, I've already donated blood.
Or I'm especially aware
that people want to talk to me again.
Because I think people need to be a little sensitive to that.
Where does the medication that changed her life come from?
Where does the blood contained in this medication come from?
Do you think it comes from
Swiss blood plasma?
I don't know.
I said no.
Or not only.
The origin of the plasma is not known.
This information lies in the company's secret.
We go to Swissmedic,
the Swiss control authority
that also monitors the origin of the medication.
Every week, specialists analyze plasma samples
and blood derivatives
that are determined for Swiss hospitals.
And this is plasma?
Yes, these are plasma pools.
So in every tube
there is an aliquot of a plasma pool.
As part of the official plasma pool testing
the companies have to provide us with these pool aliquots
where we then carry out the tests on HIV, Hepatitis B, Hepatitis C.
Do you know where the plasma comes from?
We can look it up, yes.
We can't film the page?
It belongs to the company.
This document belongs to the company.
This is a search and plasma pool test.
And here you see different pools.
Listed.
Origin of the donations.
USA, USA, USA, USA, USA, USA.
And now we take this number.
This is CU1445.
Kansas City, Chattanooga, Lansing, USA.
Here you can see how many donations
come from which center.
Strange.
And all these centers
are registered in the plasma master file of Swissmedic.
Cleveland, West 25th Street.
48 donors.
Cleveland, USA.
We decide to look around on site.
West 25th Street.
This is the address registered by Swissmedic.
A part of the plasma used in Switzerland for medication
comes from here.
This blood donation center belongs to the Australian company CSL.
Donate your plasma.
Save lives.
Earn up to $200 a month.
Everywhere we discover advertising slogans
that indicate that donors are paid for their blood.
Unlike most European countries,
it is allowed in the United States to pay for blood donations.
This is legal.
We go inside.
The center is strictly monitored.
It is impossible to talk to the staff.
You can't just come and film.
You have to stick to the official way.
Then we film from the outside.
You can film from the street, on the other side.
The blood donation center
is located in one of the poorest neighborhoods in the city.
Cleveland is a basic city.
The financial crisis in 2008 caused it to collapse.
Pastor Lester Williams knows the situation very well.
Many people from his small church community sell their plasma.
It is legal.
I don't have a problem with it if people decide to do it.
But it is strange that the companies still call it a donation.
What kind of donation is it when you pay someone for it?
It is not a donation.
It is not an invaluable donation.
A donation is voluntary.
They exploit people and profit from their economic situation.
It is not a donation.
They pay for it.
Is this plasma charged in Switzerland?
Yes.
So they make money on both sides.
Because the little that they give people here is really not much.
In Cleveland, all market leaders are represented.
CSL.
Griffolds.
We also find Octa Pharma here.
The Swiss company that produces Tamara's medication.
Your tattoos are cool.
Thank you.
Mark comes here twice a week to sell his plasma.
My expenses are currently $32 for rent.
$45 for the phone.
$50 for insurance.
So I'd have to spend between $200 and $225 a month.
And I found out that I can do it with plasma.
But the problem is that you live with such a tight budget.
We want to accompany Mark to the Octa Pharma blood donation center
and talk to the people in charge there.
But the closer we get to the center, the more hostile people we meet.
Leave the area with your camera.
This is not a private property.
It is a private property.
No, it's not.
Yes, it is.
So we ask donors outside at the parking lot.
At first it was just to get a little more money.
Just to get a little more bills and stuff.
And then it just kind of all became a regular situation.
From the start, you get $50 for the first five times as a new customer.
Then you get $20 for Thursdays and Thursdays, or twice a week.
And then you get $40.
And then it go up to $40.
How long have you been donating plasma?
Now for a year.
Started twice a week.
That's a lot.
Yes, but it's not that bad.
It's cool. It helps.
It's good for other families and good for my family.
One hand washes the other.
No one does it for any moral reasons.
No one does it because it helps other people.
That it helps people is just a side effect.
The process is well planned.
As soon as the plasma bottle is full, the donor is transferred the money to a credit card.
Here we go.
This is a plasma bank card.
It's almost like a regular credit card.
They put the money on the card immediately after you get done.
Sometimes they forget to put the money on your card.
Then you have to put that number on your card.
Because if you don't put that number on your card, you're going to be without money.
As a result of the economic crisis, the number of blood donations in the USA exploded.
From 15 million in 2007 to 32 million in 2014.
Luke Schaefer is a sociologist at the University of Michigan.
When we look at the numbers of families reporting half-hundreds of families
with an average income of less than $2 per person per day in a given month,
that has well more than doubled over a 15-year period.
And when we look at the number of families who are on food bank cards,
it has tripled.
The emergency food aid program is increasing infinitely.
When all these things are going in the same direction...
We walked into the plasma clinic down the street and asked people,
why are you here? What are you doing here?
People have lost their jobs and have no work.
In many cases, money for blood donations is their only option.
We meet Mark again at the entrance of the plasma center.
It didn't go the way he wanted.
He was rejected at the reception because his blood pressure was too high.
I wasn't able to donate blood today because of my blood pressure.
But it's very important to me.
I took my blood pressure medication,
but I don't think I ate anything sensible yesterday.
If you can't donate blood, will that be a financial issue for you?
It is. It's a problem.
Luckily, it's not about life and death.
It's not as vital stuff.
But I might have to pump on a friend.
I mean, I'll take care of it.
I'll be able to get our blood pressure straight.
That's why it's important for me to keep track of that.
We accompany Mark to the small social apartment he's been living in for a year.
Come on in and make yourselves at home.
When I had my stroke, it was about three years ago,
I went into the doctor's office.
To be quite honest, I was drinking a lot and I was doing all kinds of bad stuff.
So the next day I went to the Cleveland Clinic,
which is one of the best hospitals in Cleveland.
And the word with people that don't have a lot of money,
they basically go there for free.
And as a follow-up, I told the lady,
she said, oh yeah, you're way below our level.
I'm like, way below?
You know, there's below and there's way below.
That was an eye-opener.
There are times when, because of my own self-esteem,
I don't want to accept help.
I want to be able to say, thanks, but no thanks.
Going to an octopharmacist means making a little money.
It's necessary, at least for me it's necessary.
For Mark, like for many American blood donors,
his own blood is the only source of income.
If he got sick and couldn't donate anymore,
he would be completely penniless.
But in the long run,
the blood donations have a negative effect on his health.
Dr. David Margolies is a doctor in the city's largest public hospital.
MetroHealth is the safety net for Cleveland.
We take care of all the people,
whether they can pay or not.
For many patients we treat here in the MetroHealth clinic,
blood donations are one of the few ways to get money.
What does the specialist literature say about the long-term effects
when you donate plasma twice a week?
I couldn't find anything about it in the specialist literature.
I know from talking to my patients who donate plasma
that they're tired, they're exhausted,
they have headaches, but beyond that.
With the red cross, you can donate once a month.
They do it twice a week.
We talked to this individual who's donating blood.
He might not be able to afford a cell phone or rents,
and that is more important for his health
than the effects of donating.
Because if he doesn't have a cell phone,
he won't get a job or can't pay his bills,
and he'll freeze.
This is the dilemma that we're in.
What if you could earn extra money
while doing something great for others?
At OctoPharma Plasma, you can.
Not only are plasma donations vital
to the treatment of rare, chronic and genetic diseases.
The USA is the largest exporter of human blood plasma,
with 70% of the global market share.
To achieve this, they rely on their campaigns.
They care for the image of a country
with excellent safety standards.
The plasma business is under the umbrella
of the Food and Drug Administration.
Their seal of goodness opens the door to the global market.
Every week, loads of frozen plasma are shipped,
especially to Europe.
This reveals another aspect of the American recipe.
The many poor people who are willing to sell their blood.
They are an unlimited reserve of raw materials.
We want to find out under what conditions
the industrialized blood harvest takes place.
7 a.m. in Cleveland, at OctoPharma's parking lot.
I can't do it no more.
I'm blacked out. I don't want to do it no more.
I'm just small, and I didn't eat before I went in.
The last time, I almost killed myself.
I don't want to do it. I got a job now, thank God.
This is work. I'm not your product.
You know, I'm like a cow that gives you milk.
In some of their reports,
it sounds as if the donations are industrialized
and the controls are very limited.
But sometimes, OctoPharma ensures
that everything goes according to the rules.
But why does the Swiss company
refuse to let us access its centers?
Why does it forbid us to talk to the staff?
How does it choose its donors?
To check their methods,
we film with a hidden camera.
Inside, we discover that the donations
are filled with questionnaires at computer stations.
A long list of questions,
but only one physical examination.
The staff measures the blood pressure of the candidates.
The only precautionary measure
that should prevent the donors
from losing their blood,
because that would disrupt the process.
The beds are always covered,
blood donations like on a tape.
12 hours a day, 7 days a week.
Donations pose a risk.
They give the donors wrong information
about their health condition.
In addition, the payment inevitably attracts risk groups
that sometimes have something to hide.
They ask if you've slept with many,
if you have AIDS, tattoos or scars on your body.
Actually, a lot of strange questions.
But it's enough to simply answer no.
You are asked by a computer.
You just answer no, no, no.
Because who can know if I'm not lying
if I say my tattoo is older than two years?
It looks like it's part of the brain,
but they've pierced my vein.
It looks like I'm doing heroin to the sun.
The people come here to the center
to buy their drugs with the money.
But who am I to judge the next person?
Last summer, here in the neighborhood,
K2 was very popular.
Even if they do a test,
the drugs don't show up in your urine.
The K2 is enough to take off for five minutes.
Then you need the next dose.
Then you have to wait a few days.
Then you go back to Okta Pharma.
You get money for free.
I give up my plasma.
I get the next kick.
Everybody wins. That's the way I see it.
And the dealers have gotten used to this?
They love me.
For a very simple reason.
When Okta Pharma is there,
here or anywhere else,
they try to get somewhere to go every time
to make some money.
Okay? Listen.
You give me your card,
your Okta Pharma card,
and I'll give you a bag of tunsi.
If I don't go, it's going to get lower.
Because I'm not going to take a loss.
I'm going to drop you off there.
I'm going to make sure you get in there
and get paid work.
And then I'm going to get my money for sure.
And if you don't, you come back in
and you do the same process again.
They don't like it.
Yeah, man, you know why?
Because they're doing something
that they ain't doing right.
I don't know what the hell is going on.
You guys are here on business
with your cameras to interview this place.
What do they have to hide?
We're doing a documentation for TV
about plasma and plasma donors.
They're complaining.
They're calling the police.
They're harassing the donors coming out.
Management just advised us
that if we don't get you on the parking lot,
the security service will report you
against you guys for trespassing.
Okay, that's fine.
Thank you very much.
Okay.
Lie down, and lie down, and lie down.
One row and the other.
How many people do that?
That's crazy.
How many people do that for money?
A lot.
Can you imagine how much
your body would swallow twice a week?
That's crazy.
During our visit,
Swissmedic's experts assured us
that the plasma from which
the medicines sold in Switzerland
were not donated by paid donors.
We receive from the manufacturer
his entire documentation
about all the production steps.
He tells us where the plasma comes from,
from which country,
and whether they are
paid donations or not.
Then I have to declare
that they are unpaid donations.
So the product came from
the United States
and was not donated by paid donors?
Exactly.
So unpaid donations
are unpaid donations.
Paid blood donations
are an industry in the United States.
Yes, but they are not
the plasma that is processed
in Switzerland
as donations that are not paid.
Not anymore.
For the pharmaceutical industry,
the money that the donors receive
is not a payment,
but a compensation.
In Germany, for example,
the donors can be compensated
with about 20 euros
and are limited to 4 to 6 donations per year.
But in the United States,
amounts and frequency are far above that.
They even save the poorest people's lives.
But we know
that most centers
for plasma donations in Cleveland
pay people to donate.
I don't know that.
So that's not information
that we actually check.
What we check
is whether
the donation centers
that are set up
meet the requirements
of the Plasma Master File.
That is our task.
The Plasma Master File
is a document of several hundred pages
in which the companies
describe the plasma
and its origin.
Numerous technical details,
but nothing about the methods used.
The knowledge of the specialists
at Swissmedic also ends there.
Have you ever seen
a blood donation center
in the United States?
From CSL, for example, or Oktar Pharma?
Do you know what's going on there?
No.
Next question, please.
Is it normal
that the supervisory authorities
ask so few questions?
The authorities are held in ignorance
by the industry,
hiding behind the company secret.
The socialist deputy
Jean-Francois Steyert
is one of the best experts
of Swiss health care.
As a result,
the lack of transparency
of the pharmaceutical companies
is unacceptable.
When politics or the media
start to take an interest
in a company,
it either completely shuts down
with the risk
or there's a lot of pressure.
Lack of transparency,
profit,
lack of supervision.
To what extent does this system
pose a threat to public health?
What risks are patients
and donors exposed to?
Jean-Daniel Tissot,
dean of the Faculty of Medicine
at the University of Lausanne,
was a long-time leader
of the city's transfusion center.
He gives a warning,
Is there a difference in health
between the plasma
of a poor American
and that of a Swiss?
There's no evidence for that.
I don't think so,
because the controls
or manufacturing techniques
allow us to ensure
that all pathogens can be removed.
Maybe with the exception
of dysprion,
this special protein
that is related to cattle madness.
There's no certain evidence.
There's no zero risk.
Never.
Let's remember
the great blood scandal.
Contaminated blood
that was spread all over Europe,
including the Swiss Red Cross
and especially in France.
In these premises,
blood was collected
for transfusions.
Blood that was said
to be the safest in the world.
It has been prosecuted
for several months
for storing products
contaminated by the AIDS virus,
causing the death
of hundreds of hemophiles
and transfusions.
As a result of the scandal,
hygiene controls
around the world were tightened.
Since then,
various, but very effective
techniques have been used
to clean plasma pools.
Especially with the most dangerous viruses
that cause hepatitis and AIDS.
Jean-Jacques Huyard is a hematologist
and heads the largest
transfusion center in France in Lille.
The scandal of contaminated blood
has shaken him up.
It has been proven
that the frequency of cases
with paid blood donations
is much higher.
Of course, there are tests
that can be avoided.
But you can imagine
that a new pathogen
can intensify the problem
of inconsistency.
It doesn't make sense.
People come to the centers
to buy drugs.
That's sad.
Simply hideous.
It's disgusting.
Today, the controls
are set up.
At least for the known risks.
But a new virus
would be enough.
It would spread very quickly
and very far.
Globalization makes it possible.
To reduce the risks,
every country should produce
the plasma needed for
the care of its patients.
That's what the WHO demands.
The self-sufficiency of the countries
is definitely one of the goals
of the World Health Organization.
The countries should try
to provide for themselves.
But the goal is not autarky
for the sake of autarky,
but because self-sufficient systems
tend to be safer
and tend to provide better care.
But many parts of the world
can't provide for themselves.
They are dependent on blood donations
from abroad.
Our goal is
that the whole world
supports autarky,
but we're not there yet.
In many parts of the world,
they've made decisions
to privatize blood donations
in Europe,
in Scandinavia,
in France.
But the experts can't rule out
that one day,
a new virus will spread.
The fear of health risks
is a core issue in France.
In July 2015,
Oktar Pharma received
the approval for the French market.
The Swiss company was authorized
to send its plasma bags
and medicines
on the basis of blood plasma
to French hospitals.
The Swiss government
had until then
the French establishment
of the Monopole.
Michel Monselier
heads the Association
of Voluntary Donors.
Is the need for blood plasma
donations very high?
Yes.
And how many are there?
In France, 10,000 a day.
Is that enough?
Absolutely.
The country can always
donate blood.
More donors would be needed.
At least I hear that all the time.
No, that's not true.
That's wrong.
Today, when it comes to blood donations,
we're self-sufficient.
We've been self-sufficient
since the 1950s.
But the number of donors
has to be constantly renewed
because 60% of the donors
who donate for the first time
don't donate for the second time.
We're self-sufficient
for the simple reason
that it's a free market
that is subject to competition.
And that means?
For the production of plasma drugs,
we rely on foreign market participants.
These are pharmaceutical laboratories
that collect plasma
and pay the donors.
Isn't that illegal?
In France, it's illegal.
But drugs based on plasma
are on the free market in France.
50% of these drugs
come from private laboratories
that produce plasma
from foreign donors
from Germany, the Czech Republic,
and especially the United States.
I understand.
In France alone,
500,000 patients live
on the basis of plasma-produced drugs.
Can you explain
what has changed with OctaFarma?
It's not really OctaFarma
that has changed.
It's much more the European Union.
If a substance is approved
as a drug in the EU,
this substance is now
open to the free market
across countries.
We don't have much time.
I think in the second half of the year,
we'll get back to the heart of the matter
with the introduction of drugs.
Despite all the insurances
that are given to us today,
no one can prove
that the plasma that is used
to produce these plasma products
comes from unpaid donors.
Liberalization of the market.
Increasing health risks.
How does OctaFarma react
to all these fears?
After months of research,
the company refuses
to accept any interview.
We go to the headquarters
in the small town of Lachen
in the canton of Switzerland.
I'm in your headquarters in Lachen
and I'd like to talk to you.
Ah, I think
some of your colleagues are coming.
So I'll talk to them
and get back to you.
I'd like to remind you
that you are not allowed
to film in our building.
The best thing to do
is to leave the building
at the moment
and then, as Thomas said,
we'll take your questions
and we'll report them
through the appropriate channel.
So you will answer my questions?
We will.
You said you would answer our questions.
Our cameraman leaves
the building
and we turn off the microphones.
The head of public relations
asks us to send our questions
in writing.
He promises to pass them
on to the shareholders.
In plain German,
nothing is decided without
the consent of Wolfgang Mager,
founder and sole owner
of OctaFarma.
The doors of the company
We have a whole list
of important questions.
Not only about the health risks,
but also about the methods
of the company.
OctaFarma is not the largest
company on the plasma market,
but its turnover already reaches
1.5 billion euros
with a considerable growth rate.
Business practices have aroused
several times the suspicion
of the authorities.
The former Prime Minister,
who led the country between 2005
and 2011, has been incarcerated
and sleeps in prison tonight
for corruption and tax fraud.
An unprecedented financial scandal.
At the end of 2015,
the former Portuguese Prime Minister
José Socrates was arrested.
He was accused
of having received money from OctaFarma.
He acted as an advisor
in Brazil, where the company
was involved in a scandal
entitled blood vampirism.
OctaFarma is suspected
of having paid smear money
to officials of the Ministry of Health.
The verdict is still out,
and the company is still active in Brazil.
In France,
links between pharma industry
and politics are one of the concerns
of the donation association.
Michel Moncelier learned firsthand
how sensitive the Swiss company
can react.
My relationship with OctaFarma
is quite difficult,
because we were astonished
to learn that Wolfgang Marguer
was chosen by the then
Minister of Health,
Roselyne Bachelot,
with the Legion of Honor.
Mr. Marguer decided
to sue us,
the association,
me personally,
and my colleagues,
the then president of the association,
for damaging his reputation
and the reputation of his company.
A full-time employee,
a police officer, two gendarmes,
a locksmith and a computer scientist.
They examined our computers
to see if we had damaged
the integrity and reputation
of Mr. Marguer and his company.
There was a trial
in which Mr. Marguer was acquitted
and he was sentenced
to bear the costs of the trial.
What exactly was he afraid of?
That business opportunities
would be lost.
That is, what we had planned
was of course not right
and could damage his reputation
and the social development
of his company.
During our visit to the
OctaFarma headquarters in Lachen,
we were promised answers
to our questions.
A few weeks later,
however, the head of public relations
told us that the company
would not answer a single question
We only had one option left
to go to Heidelberg,
where Wolfgang Marguer,
the founder of OctaFarma, lives.
Hello?
Yes, good morning.
I would like to speak to Mr. Wolfgang Marguer, please.
Who are you?
I am François Pilet, I am a journalist.
Hello?
Wolfgang Marguer does not wish
to speak to journalists.
He asks the police to let us know.
Good day.
Could you please turn off the camera?
Yes.
Could you please turn it off?
He asks to turn off the camera.
Now, please.
We are on the street.
All our questions remain unanswered.
About the origin of the plasma,
the payment,
the risks associated with the extreme poverty
of the donors,
the use of drugs,
and the possibility of new epidemics.
Why does OctaFarma not answer
the concerns of Tamara and the thousands of patients
who are addicted to the drugs?
From the point of view of the people in Cleveland,
our concerns seem ridiculous.
Those who have no other resources
will always see the sale of plasma
as the lesser evil.
As long as countless patients around the world
need plasma,
the pharmaceutical industry will be there
to cover this demand.
This is America.
Everything here is a single corporation.
And without money,
nothing moves.
You see, when the market collapses,
everything shuts down.
No government checks.
So what can we do?
OctaFarma might still work.
So let's go there
and make some quick dollars.
Let's give them what they want
so we get what we want.
Mark is relieved.
He was finally able to donate blood
and received his $20.
How was your blood pressure today?
My blood pressure was pretty good.
It was lower than yesterday.
129 to 82.
That's pretty good.
What are you going to do now?
Do you want to go home and rest?
Yeah, I pretty much want to go home.
Maybe I'll take a nap.
You know, that kind of thing.
Between Mark and Tamara,
there's an invisible bond.
The pharmaceutical industry
has connected them
inseparably in their need.
If you want to meet your colleagues,
then you're not doing well.
Either you're sick
or you're in pain
that you can't go.
But family is always there.
That's the most important thing for me.
This is exploitation
of people by people.
Some people call it
a new form of cannibalism.
And if we don't pay attention
and take a detour
of ethical standards
in view of what a donation is,
what voluntary is,
if we accept to make
the body a commodity,
then we are able to do everything.
This detour of ethical standards
has already become reality.
The blood of the poor in the arms of the rich.
